JB
John W Beck
SVP, Finance & Operations, CFO

John W Beck insider trades: Ardea Biosciences, Inc./DE (RDEA) stock sales

SVP, Finance & Operations, CFO, Ardea Biosciences, Inc./DE Last trade Jun 11, 2012 35 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
14
Open-market trades
since 2006
5
Companies
last trade 2012

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where John reports to the SEC

Open-market buys and sales

14 trades reported on SEC Form 4, newest first

DateStockTypeValue
Jun 11, 2012RDEA↓ Sell$897K
Jul 25, 2011RDEA↓ Sell$391K
Aug 14, 2009RDEA↓ Sell$50K
May 20, 2009RDEA↓ Sell$75K
Jun 19, 2007MBRX↓ Sell$27K
Jun 1, 2007MBRX↓ Sell$80K
May 22, 2007MBRX↓ Sell$2K
Apr 25, 2007MBRX↓ Sell$27K
Apr 10, 2007MBRX↓ Sell$64K
Feb 26, 2007MBRX↓ Sell$26K
Dec 5, 2006MBRX↓ Sell$24K
Nov 27, 2006MBRX↓ Sell$4K
Nov 8, 2006MBRX↓ Sell$24K
Mar 1, 2006MBRX↓ Sell$8K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About John W Beck's insider trades

John W Beck is SVP, Finance & Operations, CFO at Ardea Biosciences, Inc./DE (RDEA). Since Mar 1, 2006, John has reported no open-market purchases and 14 sales worth $1.7M on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include grants and awards (20 filings), option exercises (7 filings), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every RDEA insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.